Form 4 for BBLG Bone Biologics Corp

Accepted 2021-10-19 00:00:00 ET · period of report 2021-10-15 · accession 0001493152-21-025816 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
DMI	2021-10-19	2021-10-15	BBLG	HANKEY CAPITAL, LLC	10%	C - Cnv Deriv	$0.9694	-3.43M	7.55M	-31%	-$3.33M
DI	2021-10-19	2021-10-15	BBLG	HANKEY CAPITAL, LLC	10%	I - Discretionary	$5.24	+476.2K	8.03M	+6%	+$2.50M
DI	2021-10-19	2021-10-15	BBLG	HANKEY CAPITAL, LLC	10%	G - Gift	$0.00	-1.00M	7.03M	-13%	$0
DI	2021-10-19	2021-10-15	BBLG	HANKEY CAPITAL, LLC	10%	I - Discretionary	$0.01	+476.2K	476.2K	New	+$4,762

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2021-10-15	C	A	5,928,774	$2.50	16,915,624	I BY HANKEY CAPITAL, LLC	—	—
2	Common	Common Stock	2021-10-15	I	A	476,190	$5.24	8,030,112	I BY HANKEY CAPITAL, LLC	—	—
3	Common	Common Stock	2021-10-15	G	D	1,004,310	$0.00	7,025,802	I BY HANKEY CAPITAL, LLC	—	—
4	Common	Common Stock	2021-10-15	C	D	9,361,702	$0.00	7,553,922	I BY HANKEY CAPITAL, LLC	—	—
5	Derivative	Warrants to Purchase Common Stock	2021-10-15	I	A	476,190	$0.01	476,190	I By Hankey Capital, LLC	$6.30 · 2021-10-13 to 2026-10-13	476,190 Common	(F3) Represents shares purchased in the Issuer's public offering of units, with each unit consisting of one share of Common Stock and one Warrant. The allocation of a unit is $5.24 for a common share, and $0.01 for a warrant.